Zika virus RNA (ZIKV RNA) (ZIKV RNA)

Zika virus (ZIKV) is a member of the Flaviviridae family, characterized by a positive-sense, single-stranded RNA genome of approximately 10.7 kilobases. This RNA molecule serves as the primary genetic material, functioning as both a messenger RNA for the translation of a single polyprotein and a template for the synthesis of new viral genomes via a negative-strand intermediate (Kuhn et al., 2002, Cell). In the context of drug discovery and antiviral screening, "Zika virus intracellular RNA levels" refers to the quantitative measurement of viral genomic material within host cells, typically used as a phenotypic readout to evaluate the potency of therapeutic candidates (Sacramento et al., 2017, Scientific Reports). The ZIKV genome is a critical therapeutic target; its replication is mediated by the NS5 RNA-dependent RNA polymerase, which can be inhibited by nucleoside analogs like Sofosbuvir to reduce viral load (Bullard-Feibelman et al., 2017, Antiviral Research). Effective reduction of intracellular RNA levels is essential for treating ZIKV infections, which are associated with severe neurological conditions including microcephaly in infants and Guillain-Barré syndrome in adults (Mlakar et al., 2016, NEJM). Current therapeutic strategies focus on inhibiting the replication machinery or using RNA-based technologies like siRNA to directly target and degrade the viral RNA (Saiz et al., 2016, Frontiers in Microbiology).

Other names

Zika virus genomeZIKV genomic RNAZika virus positive-sense single-stranded RNAZika virus intracellular RNA levels

Inhibition of the NS5 RNA-dependent RNA polymerase (RdRp) leading to premature chain termination of the viral RNA, or direct degradation of the viral RNA genome through antisense or RNA interference mechanisms.